Latest News

Asian patients with psoriasis have shortest visits, study shows


 

FROM JAMA DERMATOLOGY

Other differences found

In addition to visit length, they found significant differences in mean age and in the use of complex topical regimens. The mean ages of Asian, Hispanic or Latino, and non-Hispanic Black patients were 37.2, 44.7, and 33.3 years, respectively. Complex topical regimens were prescribed to 11.8% of Asian patients, compared with 1.5% of Black and 1.1% of White patients.

For practicing dermatologists, knowing for now that Asian patients have shorter visits “may bring to light some consciousness to how we practice,” Dr. Yang noted. “We may counsel differently, we may spend differing amounts of time – for reasons still unknown. But being generally aware can help us to shift any unconscious bias that may be there.”

Dermatologists, Dr. Armstrong and Dr. Wu wrote, “need to allow sufficient time to develop strong physician-patient communication regardless of patient background.”

The NAMCS – administered by the Center for Disease Control and Prevention’s National Center for Health Statistics – collects data on a sample of visits provided by non–federally employed office-based physicians.

Dr. Armstrong disclosed receiving personal fees from AbbVie and Regeneron for research funding and serving as a scientific adviser and speaker for additional pharmaceutical and therapeutic companies. Dr. Wu, Dr. Scott, and Dr. Yang did not report any disclosures.

Pages

Recommended Reading

NAFLD strongly correlated with psoriasis, PsA; risk linked to severity
MDedge Dermatology
Questionnaire for patients with psoriasis might identify risk of axial involvement
MDedge Dermatology
Topical roflumilast approved for psoriasis in adults and adolescents
MDedge Dermatology
Guidance From the National Psoriasis Foundation COVID-19 Task Force
MDedge Dermatology
Management of Psoriasis With Topicals: Applying the 2020 AAD-NPF Guidelines of Care to Clinical Practice
MDedge Dermatology
Racial Disparities in the Diagnosis of Psoriasis
MDedge Dermatology
Generalized Pustular Psoriasis: A Review of the Pathophysiology, Clinical Manifestations, Diagnosis, and Treatment
MDedge Dermatology
Study suggests psoriasis and PsA are underdiagnosed in underserved groups
MDedge Dermatology
Biosimilar-to-biosimilar switches deemed safe and effective, systematic review reveals
MDedge Dermatology
FDA approves adalimumab-bwwd biosimilar (Hadlima) in high-concentration form
MDedge Dermatology